Is an anthracycline antibiotic medication.
Treatment of various types of cancer, including:
Breast cancer
Lung cancer
Stomach cancer
Ovarian cancer
Leukemia
Lymphoma
Epialfa 10mg Injection (Epirubicin) works by interfering with the growth and division of cancer cells. It does this by inhibiting the enzyme topoisomerase II, which is essential for DNA replication and repair.
Epirubicin should be stored in a refrigerator between 2°C and 8°C (36°F and 46°F). Protect it from light and freezing.
The dosage of epirubicin will vary depending on the type of cancer being treated, the patient's overall health, and other factors.
Epirubicin is typically administered intravenously (into a vein) by a healthcare professional.
It can also be given as a continuous intravenous infusion over 24-96 hours.
Nausea and vomiting
Hair loss (alopecia)
Mouth sores
Low white blood cell count (neutropenia)
Low platelet count (thrombocytopenia)
Heart problems (cardiotoxicity)
Liver damage
Kidney damage
Skin discoloration (hyperpigmentation)
Alcohol consumption should be avoided while taking epirubicin, as it can increase the risk of liver damage.
Epirubicin can cause fatigue, dizziness, and confusion. Avoid driving or operating machinery until you know how this medication affects you.
Epirubicin is known to harm a developing fetus. It is not recommended for use during pregnancy. Breastfeeding should be stopped while taking epirubicin.
Epirubicin should only be used in children when the benefits outweigh the risks.
Kidney function should be monitored closely while taking epirubicin, as it can cause kidney damage.
Liver function should be monitored closely while taking epirubicin, as it can cause liver damage.
https://www.drugs.com/mtm/epirubicin.html
https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer-treatment/art-20048036
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin
